ClinicalTrials.gg
Status unknownNCT04147377Updated Dec 18, 2019

Effects of Behavioral Interventions Based on Sensory Cues on FOG in PD After STN-DBS

An interventional study of behavioral intervention based on sensory cues in Parkinson Disease, sponsored by Seoul National University Hospital. Status unknown. Open to participants aged 30 Years and older. Per ClinicalTrials.gov, last updated 2019-12-18.

Sponsored by Seoul National University Hospital · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Dec 2019), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
60
Allocation
Not applicable
Ages
30 Years and older
Sex
All
01

Study summary

The investigators aims to assess the effectiveness of behavioral interventions based on sensory cues on freezing of gait in patients with Parkinson's disease after bilateral subthalamic nucleus deep brain stimulation.

Read the detailed description

Freezing of gait (FOG) leads to falling and is one of the major determinants of quality of life and prognosis in Parkinson's disease (PD). Previous evidence suggests that subthalamic nucleus deep brain stimulation (STN-DBS) improve off-medication FOG but not on-medication FOG in patients with PD. Furthermore, off-mediation FOG persist or even worsen after STN-DBS in some PD patients.

Although visual and auditory cues are known to improve FOG in research setting, it is unclear whether these cues are effective for FOG in real clinical setting. Most previous studies have used wearable devices to use sensory cues, but such devices are difficult to apply in clinical practice.

Therefore, this study aims to investigate the effectiveness of behavioral interventions based on visual and auditory cues in patients with PD after bilateral STN-DBS. Participants undergo clinical evaluations including the Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Frontal Assessment Battery (FAB), Unified Parkinson 's Disease Rating Scale (UPDRS), Freezing of Gait-Questionnaire (FOG-Q), and the average number of falling over the last week. Then, participants receive behavior intervention training that includes how to apply visual and auditory cues to freezing of gait in real clinical practice. To investigate the education effect, FOG-Q and the average number of falling over the last week are repetitively assessed at 2-week and 4-week follow-ups using a phone call.

02

Conditions studied

  • Parkinson Disease

Browse trials for

Keywords

  • Parkinson's disease
  • Freezing of gait
  • visual cue
  • auditory cue
  • subthalamic nucleus
  • deep brain stimulation
03

In context

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,097 are open to participants now.

This study's planned enrollment of 60 is above the median of 40 across 3,365 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

Seoul National University Hospital is the lead sponsor of 1,897 studies on the registry; 273 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 2 (17%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with Parkinson's disease who are aged 30 years or older
  • Patients who underwent bilateral subthalamic nucleus deep brain stimulation
  • Patients who complain of freezing of gait

Exclusion criteria

Exclusion Criteria:

  • Patients who have already used sensory cues for freezing of gait in clinical practice
  • Patients with MMSE scores of 18 or lower
  • Patients with Hoehn-Yahr scale 5
  • Patients who have neurological symptoms associated with neurological disorders other than Parkinson's disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
60 participants (estimated)

Study arms

  • Experimental
    PD with FOG

    Patients with Parkinson's disease who complain of freezing of gait

    Behavioral: behavioral intervention based on sensory cues

Interventions

  • Behavioralbehavioral intervention based on sensory cues

    Patients will receive behavior intervention training that includes how to apply visual and auditory cues to freezing of gait in real clinical practice.

06

What researchers measure

Primary outcomes

  1. Change from baseline to 4-week f/u in FOG-Q subscore (Q4+Q5+Q6)

    The FOG-Q will be used to determine the efficacy of behavior intervention based on sensory cues.

    Time frame: baseline, after 4 weeks

  2. Change from baseline to 4-week f/u in the number of falling

    We will ask about the average number of falling over the last week at baseline and at 4-week f/u.

    Time frame: baseline, after 4 weeks

Secondary outcomes

  1. Change from baseline to 4-week f/u in FOG-Q total score

    The FOG-Q will be used to determine the efficacy of behavior intervention based on sensory cues.

    Time frame: baseline, after 4 weeks

  2. Change from baseline to 2-week f/u in FOG-Q

    The FOG-Q will be used to determine the efficacy of behavior intervention based on sensory cues.

    Time frame: baseline, after 2 weeks

  3. Change from baseline to 2-week f/u in the number of falling

    We will ask about the average number of falling over the last week at baseline and at 2-week f/u.

    Time frame: baseline, after 2 weeks

  4. Change from baseline to 2-week f/u in FOG-Q subscore (Q4+Q5+Q6)

    The FOG-Q will be used to determine the efficacy of behavior intervention based on sensory cues.

    Time frame: baseline, after 2 weeks

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 18, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04147377
Responsible party
BS Jeon (Professor, Seoul National University Hospital) — Principal investigator
First posted
Nov 1, 2019
Start date
Jan 1, 2020 (estimated)
Primary completion
Dec 31, 2020 (estimated)
Completion
Dec 31, 2020 (estimated)
Last update
Dec 18, 2019

Study contacts

Beomseok Jeon, Professor
Contact
brain@snu.ac.kr
+82-2-2072-2876
Beomseok Jeon, Professor
principal investigator · Seoul National University Hospital

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Dec 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion